MedTrace Logo

A Multicenter Prospective Observational Cohort Based on a Breast Cancer Medical Record Database in China

NCT06591039 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20000

Last updated 2024-09-19

No results posted yet for this study

Summary

1. To construct a prospective, multi-center breast cancer treatment cohort in China, and analyze the factors affecting breast cancer diagnosis and treatment.
2. To evaluate the diagnosis and treatment and prognosis of breast cancer among patients in different regions and hospitals.

Conditions

  • Breast Neoplasms

Interventions

PROCEDURE

The study did not involve intervention in the patient's treatment regimen

This study is based on a prospective database platform to register the occurrence, treatment and prognosis of breast cancer in China, so there is no clear exposure factor. This study was a prospective cohort study, which did not intervene in exposure factors, but only assessed the occurrence, treatment, and prognosis of breast cancer in China.

Sponsors & Collaborators

  • Fudan University

    lead OTHER

Principal Investigators

  • Jiong Wu, M.D · Cancer Hospital/ Institute, Fudan University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2025-07-01
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06591039 on ClinicalTrials.gov